Imipenem/Cilastatine Fresenius Kabi 500 mg - 500 mg inf. sol. (pwdr.) i.v. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Cilastatin Sodium 530 mg - Eq. Cilastatin 500 mg; Imipenem Monohydrate 530 mg - Eq. Imipenem 500 mg
Available from:
Fresenius Kabi SA-NV
ATC code:
J01DH51
Pharmaceutical form:
Powder for solution for infusion
Administration route:
Intravenous use
Therapeutic area:
Imipenem and Enzyme Inhibitor
Product summary:
CTI Extended: 416595-01
Authorization status:
Commercialised: No
Authorization date:
2012-04-03
